Back
Venture Capital
BioHealth Innovation Newsletter - March 16, 2021
To view the newsletter click here.
- Marina Massingham, CEO, Aifred Health, & Laurent Waessa, Sr. Business Development Advisor, Québec Government Office in New York, Virtually Visit BioTalk
- VIRTUAL SBIR and OTHER NON-DILUTIVE FUNDING SOURCES WORKSHOP with 1:1 PARTNERING – March 17-19, 2021 (2)
- Digital Health Forum Presented by EAGB and BioHealth Innovation Registration, Thu, Mar 25, 2021 at 1:00 PM | Eventbrite
- Top 10 U.S. Biopharma Clusters (BHCR number 4 but metrics improved over 2020)
- Innovation Showcase - American College of Cardiology (April, 1)
- After merger, College Park startup IonQ plans to go public with $2 billion valuation
- VLP Therapeutics names seasoned biotech venture capitalist Miwa Toyoda as CBO | National News | kpvi.com
- Novavax Says Its COVID-19 Vaccine is 96% Efficacious | Time
- J&J plans to produce up to 3 billion doses of vaccine next year, United States News & Top Stories - The Straits Times
- Leveraging Artificial Intelligence in Human Health (Rich Bendis will Facilitate)
- Opinion | A Vaccine Maker’s Investment: Emergent BioSolutions Responds - The New York Times
- SPAC Alexandria Agtech/Climate Innovation Acquisition files for a $250 million IPO | Nasdaq
- Rockville-based Pediametrix receives $1M from National Science Foundation for R&D - Technical.ly DC
- Researchers in a Virginia Lab Lay Groundwork for U.S.-Made Drugs - Bloomberg
- Cartesian Therapeutics Initiates Phase 2 Clinical Trial of First RNA-Engineered Cell Therapy for Frontline Cancer · BioBuzz
- BioHealth Capital Region Women Making Waves in Venture Capital · BioBuzz
- 5 Questions with Destinie Burgan, Upstream Supervisor of Manufacturing, Emergent BioSolutions · BioBuzz
- Inova and University of Virginia School of Medicine open new campus | Headlines | insidenova.com
- Innovation alliance unveils new name and strategic plan for Western Virginia | Business Local | roanoke.com
To view the newsletter click here.